Home
Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. Market Share Analysis for August 2026

Sarepta Therapeutics, Inc. is a medical research and drug development company with corporate offices and research facilities in Cambridge, Massachusetts, United States.

Arts & Entertainment > Music

Domainsarepta.com

Year Founded1980

Employees501 - 1000

Annual Revenue> $1B

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc. (including company regionals)

sarepta.com

See more website traffic and engagement information

Sarepta Therapeutics, Inc. Revenue up to August 2026 is > 1B

revenue generated by Sarepta Therapeutics, Inc. top domains

Sarepta Therapeutics, Inc. top domains revenue over 3 years

Revenue for Sarepta Therapeutics, Inc. top domains

sarepta.com> 1B

See more with Sales Intelligence

Total visits to Sarepta Therapeutics, Inc.'s top domains

Understand Sarepta Therapeutics, Inc. market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

sarepta.com22.5K

See more with Sales Intelligence

Avg. visit duration in Sarepta Therapeutics, Inc.'s top domains

Analyze Sarepta Therapeutics, Inc. engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

sarepta.com00:00:19

See more with Sales Intelligence

Avg. pageviews on Sarepta Therapeutics, Inc.'s top domains

See how Sarepta Therapeutics, Inc. keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

sarepta.com1.83

See more with Sales Intelligence

Sarepta Therapeutics, Inc. top competitors by domain

Top similar sites in August 2026, ranked by their affinity

mda.orgCompany NameMuscular Dystrophy AssociationEmployees501 - 1000HQUnited States, Arizona, TucsonAnnual revenue$75M - $100MTotal visits170.8KHealth > Health - Other

Top technologies used by Sarepta Therapeutics, Inc.

These are the website technologies, by industry, used by Sarepta Therapeutics, Inc. top domains

Advertising (8)

DoubleClick

Conversion & Analytics (6)

Google Analytics

Social (4)

Instagram

Content Management System (3)

Drupal

More Technologies

16

See all

News & Signals from Sarepta Therapeutics, Inc.

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsSarepta Therapeutics had issues with unprofitable on Sep 10th '26.* Sarepta beat quarterly earnings and revenue expectations, reporting $0.64 in EPS and $401.25 million in revenue, but revenue declined 34.3% year over year and the company remained unprofitable.

NewsSarepta Therapeutics had issues with unprofitable on a net-margin basis on Sep 8th '26.* Sarepta beat quarterly earnings and revenue expectations, reporting $0.64 in EPS and $401.25 million in revenue, but revenue fell 34.3% year over year and the company remained unprofitable on a net-margin basis.

NewsUltragenyx identified as competitor of Sarepta Therapeutics on Sep 1st '26.Ultragenyx's leading competitors are Biomarin Pharmaceutical Inc (NASDAQ: BMRN) (FRA: BM8) and Sarepta Therapeutics Inc (NASDAQ: SRPT) (FRA: AB3A).